WallStreetZen

NASDAQ: AZN
Astrazeneca Plc Stock

Overview
ForecastEarningsDividendOwnership
$49.19-0.23 (-0.47%)
Updated Apr 13, 2021
AZN Price
$49.19
Fair Value Price
N/A
Market Cap
$129.07B
52 Week Low
$46.48
52 Week High
$64.94
P/E
40.32x
P/B
8.26x
P/S
4.93x
PEG
0.82x
Dividend Yield
2.85%
Revenue
$26.62B
Earnings
$3.14B
Gross Margin
80.1%
Operating Margin
19.62%
Profit Margin
11.8%
Debt to Equity
3.27
Operating Cash Flow
$5B
Beta
0.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Expand Score
High
Medium
Low
45
Industry average

Reasons for this score

AZN ($49.19) is trading below its intrinsic value of $202.69, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
AZN is poor value based on its earnings relative to its share price (40.32x), compared to the US market average (19.9x)
Valuation
AZN is poor value based on its earnings relative to its share price (40.32x), compared to the US Drug Manufacturers - General industry average (8.76x)
Valuation

1 of 13

AZN News

Valuation

AZN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
40.32x
Industry
8.76x
Market
19.9x
AZN is poor value based on its earnings relative to its share price (40.32x), compared to the US market average (19.9x)
Valuation
AZN is poor value based on its earnings relative to its share price (40.32x), compared to the US Drug Manufacturers - General industry average (8.76x)
Valuation

AZN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.26x
Industry
5.12x
Market
-0.01x
AZN is good value based on its book value relative to its share price (8.26x), compared to the US market average (-0.01x)
Valuation
AZN is poor value based on its book value relative to its share price (8.26x), compared to the US Drug Manufacturers - General industry average (5.12x)
Valuation

AZN price to earnings growth (PEG)

For valuing profitable companies with growth potential
AZN is good value based on it's Price to Earnings and rate of earnings growth, measured by PEG ratio (0.82x)
Valuation

AZN's financial health

Profit margin

Revenue
$7.4B
Net Income
$1.0B
Profit Margin
13.6%
AZN's Earnings (EBIT) of $5.22B are insufficient to safely cover interest payments on company debt ($20.38B)
Financials
AZN's profit margin has increased (+6.8%) in the last year from (5%) to (11.8%)
Financials

Assets to liabilities

Assets
$66.7B
Liabilities
$51.1B
Debt to equity
1.3
AZN's short-term liabilities ($20.31B) exceed its short-term assets ($19.54B)
Financials
AZN's long-term liabilities ($30.78B) exceed its short-term assets ($19.54B)
Financials
AZN's debt has increased relative to shareholder equity (3.27), over the past 5 years ago (2.25)
Financials
AZN's debt to equity ratio (3.27) is considered high
Financials

Cash flow

Operating
$1.8B
Investing
$138.0M
Financing
-$2.2B
AZN's operating cash flow ($4.80B) is sufficient to service the company's debt ($20.38B)
Financials

Astrazeneca Stock FAQ

What is Astrazeneca's quote symbol?

(NASDAQ: AZN) Astrazeneca trades on the NASDAQ under the ticker symbol AZN. Astrazeneca stock quotes can also be displayed as NASDAQ: AZN.

What is the 52 week high and low for Astrazeneca (NASDAQ: AZN)?

(NASDAQ: AZN) Astrazeneca's 52-week high was $64.94, and its 52-week low was $46.48. It is currently -24.25% from its 52-week high and 5.83% from its 52-week low.

How much is Astrazeneca stock worth today?

(NASDAQ: AZN) Astrazeneca currently has 1,312,000,000 outstanding shares. With Astrazeneca stock trading at $49.19 per share, the total value of Astrazeneca stock (market capitalization) is $129.07B.

Astrazeneca stock was originally listed at a price of $18.00 in Dec 31, 1997. If you had invested in Astrazeneca stock at $18.00, your return over the last 23 years would have been 173.28%, for an annualized return of 4.47%.

How much is Astrazeneca's stock price per share?

(NASDAQ: AZN) Astrazeneca stock price per share is $49.19 today (as of Apr 13, 2021).

What is Astrazeneca's Market Cap?

(NASDAQ: AZN) Astrazeneca's market cap is $129.07B, as of Apr 15, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Astrazeneca's market cap is calculated by multiplying AZN's current stock price of $49.19 by AZN's total outstanding shares of 1,312,000,000.
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.